Track 12: Combination & Conjugate Vaccines


Progressively, more sicknesses are getting antibody preventable, yet keeping up network and supplier acknowledgment requests that the quantity of infusions doesn't increment. Blend conjugate antibodies speak to an inescapable and significant development. This paper surveys the adequacy and security of mix conjugate antibodies, including immunological instruments hidden cooperation’s among immunization epitopes, the job of immunological memory, and relates of invulnerability. Explicit consideration is given to the involvement in blend antibodies against each of Haemophilus influenza type b, Streptococcus pneumonia and Neisseria meningitidis. The ramifications of these discoveries for various networks are examined, key zones for further research recognized and suggestions for post-licensure checking tended to.


  • Yellow fever
  • OPV Vaccine

Related Conference of Track 12: Combination & Conjugate Vaccines

August 22-23, 2022

4th World Congress on Vaccine and Immunology

Toronto, Canada
September 05-06, 2022

42nd Global Summit and Expo on Vaccines & Immunology

Paris, France
November 04-05, 2022

34th Annual Congress on Vaccine and Clinical Trials

Toronto, Canada
November 17-18, 2022

2nd Global Summit on Vaccines and Immunology

Berlin, Germany
February 20-21, 2023

International Conference on Vaccine Research

Madrid, Spain

Track 12: Combination & Conjugate Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in